SHORT REPORTS
Controlled trial of physiotherapy and occupational therapy for Parkinson's disease Physiotherapy is used routinely in Parkinson's disease, but there are no properly controlled trials to support its use. We describe such a trial.
Patients, methods, and results
Twenty-four patients with Parkinson's disease attending the neurological clinic were included in a controlled cross-over trial of physiotherapy and occupational therapy. Medication was stable in all cases, and no patient had received physiotherapy or occupational therapy before.
Speech, gait, posture and balance, tremor in the worst arm, and rigidity in the worst arm were assessed and graded as normal (0) to severely disabled (4); and the following specified activities were timed: rising from a seat, walking 6 m, turning round, walking back to the chair, and sitting down; number of times the patient could open and close his fist fully in 10 seconds (worst hand); time taken to insert a set of pegs into a peg board; and time taken to insert a sheet of cardboard into an envelope. After initial assessment the patients received either active or inactive treatment. They were then reassessed, and after a three-month gap crossed over to receive the alternative treatment. For each treatment the patients attended hospital eight times in four weeks.
During active treatment physiotherapy and occupational therapy were planned according to individual needs. Active physiotherapy was geared to positive treatment using proprioceptive neuromuscular facilitation and Bobath and Peto methods. These were used to improve rotation, balance, and walking, reduce festination, and increase the range of movement where rigidity was a problem. Active occupational therapy was aimed at improving personal independence and functional activities, such as mobility, feeding, dressing, and cooking. During active therapy relatives were invited to observe treatment and encourage the patient's activities at home. Inactive treatment consisted of infrared radiation to the thorax and diversional activities such as table games and crafts, with minimal supervision.
Of the 24 patients (18 men, average age 68-9 years; six women, average age 731 years), eight were withdrawn: one during the initial treatment, four during the three-month gap before cross-over, and three during the second course of treatment. One of these eight patients died, four required treatment for other illnesses, and three could not continue for social reasons. Twenty-three patients completed an initial course, and 16 the full cross-over study.
Results (table) obtained in each test in the assessment made by the doctor before treatment were compared with those obtained immediately after treatment using the sign test for comparison of grades (assessments 1-5) and Wilcoxon's rank paired test for the timed data (assessment 6-9). In no test was there a significant change after treatment.
Comment
Our results suggest that remedial therapy in a hospital outpatient department is not helpful for patients with Parkinson's disease whose condition is relatively stable and whose medication does not require adjustment. We studied outpatients whose neurological condition Results of assessments (expressed as mean scores before and after treatment) 
Patients, methods, and results
Serum complement was studied in 110 patients with various forms of glomerulonephritis. CH50 activity was measured by a kinetic method,' and C3 and C4 concentrations by single radial immunodiffusion3 with Behringwerke Partigen plates. Thirteen patients had CH5,0 activity more than 2 standard deviations (SD) above the normal mean. A further seven were picked at random from those with high normal levels (1-2 SD above the mean). These 20 patients were matched with a control group of 20 subjects chosen from the 60 patients with CH6,0 activity ± 1 SD from the normal mean.
They were selected,firstly, to match perfectly for histological diagnosis and sex, then to match as closely as possible for age, duration of the disease, degree of proteiauria, and excretory function (creatinine clerance). As a result the two goups at -the start were perfectly matched for histological diagnosis and sex; well matched for mean age (37 v 36 years), duration of disease, (6 5 v -70 -yrs), proteinuria-(36 v2B g/24 h), creatinine clearance (97 v 109 1/24 b), and hypertension (6/20 v 5/20); but the plasma creatinine concentration was significantly higher in the "high-complement" group than in the controls (144 v 1 0.mol/l (1I6 v 1-2 mg/100 ml); p <0 01).
The figureshowa*eiprogressoftenalfunction,as judged by plasma creati- 
Comment
The results of this study fail to show any beneficial response to lecithin in 12 patients with Friedreich's ataxia. Barbeau described a 35% mean improvement in 10 patients treated openly with lecithin granules for a mean of 23-9 weeks, with significant improvement after two weeks and maximum response at four weeks,2 and other workers reported some improvement with choline chloride.3 A more recent study, however, suggested that performance may actually decline in patients with Friedreich's ataxia treated with lecithin,' and animal studies have cast doubt on the idea that increased serum choline concentrations alter the functional activity of acetylcholine at central receptor sites.5
Because of the previous reports of early substantial improvement with lecithin2 and the difficulty of patients in tolerating the large amounts of chocolate necessary for the double-blind study we did not feel justified in embarking on a more prolonged trial. Unless lecithin can be shown to be an effective cholinergic agent there seems no
